Jeffrey Miller
University of Minnesota, USA, United States
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Co-Activating Tandem (CAT) CARs leverage heterogeneous activating signals to optimize NK cell functionality (#158)
4:45 PM
Madeline Lee
Poster Session One
Targeting the KRAS oncoprotein sensitizes pancreatic cancer to NK cell therapy (#174)
2:50 PM
Paarth B Dodhiawala
Lightning Session One
Response to g-NK therapy is associated with higher CD8+ T cells and lower MDSC in Bone Marrow of Multiple Myeloma Patients (#199)
8:00 PM
Aimee Merino
Poster Session Two
Translating NK cell biology into the clinic: cells products versus engagers (124310)
9:40 AM
Jeffrey Miller
NK cells in the Clinic I